|
|
 |
|
RX: Ims Health Inc - Stock News |
Enter Ticker:
|
|
| Nov 20, 2009 |
IMS Health Up 54.3% Since SmarTrend's Buy Recommendation |
| Nov 19, 2009 |
The Masters of the Universe are back – CNNMoney |
| Nov 17, 2009 |
RX, ECL, PNK, CBB, PWE and EQR Receives Analytical Coverage fromWallStSense.com |
| Nov 17, 2009 |
Par Pharmaceutical granted final approval to market generic Ultram ER |
| Nov 17, 2009 |
IMS Health to Release Oncology Quantifier in January 2010 |
| Nov 16, 2009 |
Par Pharmaceutical Receives Final Approval to Market Generic Ultram(R) ER |
| Nov 14, 2009 |
IMS to be Acquired by Private Funds |
| Nov 12, 2009 |
BiomedReports: News and FDA Updates for AVANIR (NASDAQ:AVNR), Adamis (OTC:ADMP), IMS (NYSE:RX) |
| Nov 11, 2009 |
United States : Mylan subsidiary receives FDA approval for its Lansoprazole DR Capsules ANDA |
| Nov 11, 2009 |
Stock research report available on IMS Health (NYSE:RX) from SmarTrend Analytics |
| Nov 11, 2009 |
IMS Health to Launch Oncology Quantifier, Delivering Integrated Insights for Enhanced Market Measurement, Commercial Strategies |
| Nov 11, 2009 |
IMS Health Enters into Agreement to be Acquired by TPG and CPP Investment Board |
| Nov 10, 2009 |
Mylan Receives FDA Approval for Generic Version of Prevacid(R) Through its Subsidiary Matrix Laboratories |
| Nov 10, 2009 |
Big Pharma & Biotech |
| Nov 10, 2009 |
Big Pharma & Biotech |
| |
| ZACKS COMMENTARY FOR RX |
| Nov 16, 2009 | Zacks Equity Research: Report for RX | | Nov 13, 2009 | Zacks Blog: IMS to be Acquired by Private Funds | | Nov 13, 2009 | Zacks Blog: Another Win for Mylan | | Nov 10, 2009 | Industry Outlook: Big Pharma & Biotech | | Nov 10, 2009 | Zacks Analyst Interviews: Big Pharma & Biotech | | Nov 09, 2009 | Zacks Blog: Big Pharma and Biotech | | Oct 22, 2009 | Zacks Blog: IMS Ahead of Zacks Estimate | | Sep 22, 2009 | Zacks Blog: Zacks #5 Rank Additions for Tuesday | | Jun 17, 2009 | Zacks Blog: Zacks #5 Rank Additions for Wednesday | | Feb 05, 2009 | Zacks Blog: IMS Health Beats 50-day MA |
|
|